echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Introduction to the classification of tumor research models and the advantages and applications of tumor organoids

    Introduction to the classification of tumor research models and the advantages and applications of tumor organoids

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent decades, our understanding of the occurrence of cancer has greatly improved


    Figure 1.


     

    Tumor research model competition


    Figure 2.


     

    2D cells: widely used due to their ease of proliferation, low maintenance costs, and ease of functional testing


     

    Patient-derived xenografts (PDXs): Capable of recapitulating the biology of human tumors, but time-consuming and expensive to use, PDXs have also demonstrated the ability to evolve mouse-specific tumors and have sparked interest in experiments using animal models.


     

    Tumor organoids: Compared with PDX, tumor organoids have lower cost and higher efficiency, and can simulate normal tissues and tissues of different stages of the cancerous process.


     

    Organoids and the tumor microenvironment: Initially, tumor organoids were labeled "imperfect" due to their inability to reproduce TME, but with the development of organoid technology, tumor organoids have been upgraded again: organoids are implanted into highly vascularized Tumor vascularization modeling can be achieved either through gene editing or in combination with mixed cell co-culture (using a microfluidic platform)


     

    There have been many organoid models established from samples from different cancer patients, such as colon, esophagus, stomach, brain, prostate, pancreas, liver, breast cancer and other organoids


     

    Tumor Organoids & Drug Sensitivity Testing

    Figure 3.


    (A) Human cancer tissue containing cancer cells, adult stem cells, pluripotent stem cells, or tumor stem cells, first mechanically and chemically broken down into very small fragments, cell clusters, or single cells and decomposed under appropriate 3D conditions with ECM The components are cultured in a hydrogel


     

    PDOs can be used to study drug resistance, metabolism, differentiation, and cancer gene function.


     

    Table 1.


     

    In addition, the clinical relevance and predictive efficacy of organoids for cancer drug screening have been well established in multiple studies, and clinical trials based on PDOs models have focused on tumors with high morbidity and mortality.


     

    Common tumor organoids and their culture systems

    Some growth factors and inhibitors are required in the organoid culture medium, and different combinations of growth factors and inhibitors in the culture medium contribute to the generation of different component lineages in the organoids


     

    Table 2.


    MCE provides a series of recombinant proteins for organoid culture with high purity, high biological activity and low endotoxin, small molecules required for organoid culture, and commonly used research dyes to help scientific research!

     

    ● High purity ● High biological activity ● Low endotoxin level ● Stable consistency ● Complete specifications

     

    cytokine

    Human EGF

    Epithelial tissue growth factor; EGF binds to EGF receptors and induces proliferative changes
    .

    Factors required for the culture of gastrointestinal tract, liver, thyroid, brain and other organoids
    .

    Human FGF-2/4/9/10

    FGFs have important roles in mesoderm induction, limb development, neural induction, and neurodevelopment during early development
    .
    In mature tissues, FGFs are essential for angiogenesis, keratinocyte organization, and wound healing processes
    .

    For example, FGF-basic (FGF-2), FGF-10 are common organoid culture Niche factors, such as liver organoids, prostate organoids
    .

    Human HGF

    The HGF/Met signaling pathway promotes tumor growth, invasion and migration
    .

    HGF acts as a mitogen for hepatocytes for use in hepatic organoid culture
    .

    Human Wnt3a

    Wnts are involved in the regulation of cell development, proliferation, differentiation, adhesion, polarity, cell-cell communication, survival and self-renewal functions
    .

    Wnt3a plays an important role in the expansion capacity of organoids and is one of the most commonly used culture factors
    .

    Human BMP-4

    BMPs play crucial roles in embryogenesis, development and maintenance of tissue homeostasis
    .
     

    In vitro, BMP-2 and BMP-4 are widely used to generate hepatocytes from induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs)
    .
     

    Human Noggin

    ,、

    Noggin

    Human DKK-1

    DKK-1Wnt ,

    Y-27632 dihydrochloride 

    Rho ;

    A 83-01

    ALK4/5/7 ;

    MCE ,

    1.
    Hanxiao Xu,Dechao Jiao,Aiguo Liu,Kongming Wu.
    Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    J Hematol Oncol.
    2022; 15, 58.

    2.
    Malia Alexandra Foo, Mingliang You, Lingzhi Wang, Boon‑Cher Goh, et al.
    Clinical translation of patient-derived tumor organoids- bottlenecks and strategies Preclinical tumor models are an important platform for mechanistic research and testing of new drugs.
    Biomark Res .
    2022 Mar 10;10(1):10.

    3.
    Jarno Drost, Hans Clevers.
    Organoids in cancer research.
    Nat Rev Cancer.
    2018 Jul;18(7):407-418.

    4.
    Bauer L.
    LeSavage, Sarah C .
    Heilshorn, et al.
    Next-generation cancer organoids.
    Nat Mater.
    2022 Feb;21(2):143-159.

    5.
    Zilong Zhou, Lele Cong, Xianling Cong.
    Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid -on-a-Chip and Living Organoid Biobank.
    Front Oncol.
    2021 Dec 30;11:762184.

    6.
    Colin Rae, Francesco Amato, Chiara Braconi.
    Patient-Derived Organoids as a Model for Cancer Drug Discovery.
    Int J Mol Sci.
    2021 Mar 27;22(7):3483.

    7.
    Georgios Vlachogiannis, Nicola Valeri, et al.
    Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
    Science.
    2018 Feb 23;359(6378):920-926.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.